1900. Low Prevalence of Protective Antibodies to Measles among Young Adults in Argentina
Session: Poster Abstract Session: Antiviral Therapies
Saturday, October 6, 2018
Room: S Poster Hall
  • Background: In the last years, there has been an increase in incidence of cases of measles in high and middle-income countries. In Argentina, measles elimination was achieved in 2000, with no circulation of measles virus since then; vaccination is compulsory (2 doses MMR vaccine) and coverage is reported to be roughly 85%. The aim of this study was to determine seroprevalence of antibodies to measles in adults, analyzed according to HIV status.

    Methods: Cross-sectional study. All serologic tests requested for measles antibodies in patients aged >18 years between Jan2015-Dec2017 in an Infectious Diseases Reference Center in Buenos Aires were retrieved and analyzed according to HIV status and age group.  All determinations were done with VIDAS¨ Measles IgG, Biomeriex. Chi2 and Fisher's exact tests were used for comparisons.

    Results: We included 2663 patients with determinations for measles performed in the mentioned period. Of those, 348 were HIV(+), with mean(±SD) age: 34.7(±6.2) years, 85% male (86% MSM), mean(±SD) nadir CD4(cells/mm3): 369.6(±219.5); 89% VL< 50 copies/mL; and 2315 were HIV(-), with mean age(±SD): 31(±5.9) years, 67% female. There was a high proportion of seronegative subjects to measles in both groups, but significantly higher in HIV+ patients (40.8% vs 33.2%; p=0.005). However, when analyzed by age group, in those < 40 years the proportion of seronegativity to measles was higher (HIV+: 45.3% vs 31.3%, p=0.02; HIV-: 38.3% vs 20.2%, p< 0.001; fig 1). Patients older than 50 years (the most prone to having been exposed to measles virus) had the highest prevalence of measles antibodies (> 92% in both groups; fig 2); and those younger than 40, the lowest (55% in HIV+ and 62% in HIV-). Stratification by gender did not change any of these findings. In HIV+ persons, seronegativity to measles was not associated with nadir of CD4<200 (p=NS).

    Conclusion: We found a very high proportion of subjects without protective antibodies to measles among those < 40 years (higher in HIV+ patients). This is interesting since in Argentina the vast majority of people < 40 should have been vaccinated at least once. Lack of circulation of measles might accelerate waning of antibodies. There might be an increased risk of measles in young people, especially in HIV+ persons; measures to evaluate this situation and eventually (re)vaccinate susceptible persons is warranted.

    Emiliano Bissio, MD1, Cristián Biscayart, MD2, Veronica Cisneros, MD2, Maria Eugenia Perez Carrega, MD1, Isabel Cassetti, MD2 and Jose Luis Montes, MD1, (1)MSD Argentina, Buenos Aires, Argentina, (2)FUNCEI, Buenos Aires, Argentina


    E. Bissio, MSD: Employee , Salary .

    C. Biscayart, None

    V. Cisneros, None

    M. E. Perez Carrega, MSD: Employee , Salary .

    I. Cassetti, None

    J. L. Montes, MSD: Employee , Salary .

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.